The charts of the producer of medical equipment are holding up well, though its shares eventually could run into resistance.
Alhough a key chart shows a new high is possible, the stock of this enterprise software giant could be disappointng for a while.
Now the one thing you need to worry about with MSFT, as you have to do with all of the techies, is the GDP.
CEO Satya Nadella has been ahead of the curve focusing on the cloud.
I'm currently in a bearish butterfly against resistance on NVDA.
Our latest analysis and strategy on the graphics processing chip manufacturer.
All three are names that can survive if the shelter-in-place order in various areas in the United States extends post-Easter, and they'll benefit beyond COVID-19.
MRVL has made a low with the broad market but I would not rule out a partial pullback to retest that low.
Let's review the charts and indicators.
MSFT might dip briefly below $150 and that is probably a dip to buy.